U
Medite Cancer Diagnostics, Inc. MDIT
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

09/30/2018 06/30/2018 03/31/2018 12/31/2017 09/30/2017
Revenue 2.39M 2.28M 1.51M 1.96M 1.69M
Total Other Revenue -- -- -- -- --
Total Revenue 2.39M 2.28M 1.51M 1.96M 1.69M
Cost of Revenue 925.00K 1.22M 1.17M 2.90M 1.32M
Gross Profit 1.47M 1.06M 335.00K -936.00K 369.00K
SG&A Expenses 1.36M 762.00K 919.00K 2.02M 1.25M
Depreciation & Amortization 62.00K 68.00K 71.00K 80.00K 110.00K
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 2.49M 2.30M 2.47M 5.01M 3.10M
Operating Income -95.00K -28.00K -960.00K -3.05M -1.41M
Income Before Tax -735.00K -559.00K -1.40M -3.12M -1.61M
Income Tax Expenses -- 4.00K -- -491.00K --
Earnings from Continuing Operations -735.00K -563.00K -1.40M -2.63M -1.61M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -735.00K -563.00K -1.40M -2.63M -1.61M
EBIT -95.00K -28.00K -960.00K -3.05M -1.41M
EBITDA -33.00K 40.00K -889.00K -2.97M -1.30M
EPS Basic -0.01 -0.01 -0.04 -0.09 -0.06
Normalized Basic EPS -0.01 -0.01 -0.02 -0.07 -0.04
EPS Diluted -0.01 -0.01 -0.04 -0.09 -0.06
Normalized Diluted EPS -0.01 -0.01 -0.02 -0.07 -0.04
Average Basic Shares Outstanding 72.37M 55.47M 39.17M 29.58M 27.70M
Average Diluted Shares Outstanding 72.37M 55.47M 39.17M 29.58M 27.70M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings